Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Multiple sklerose
by Highest Patent Value in the United Kingdom in 2022

The Multiple sklerose top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Multiple sklerose Key Players in the United Kingdom. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Multiple sclerosis is a progressive autoimmune disease that damages the insulating covers of brain cells. Depending on the brain region affected, it causes symptoms such as physical and mental dysfunction, fatigue, pain, depression, and anxiety [R+].
#
Company Name
Region
Tech Topics
Total
1
Avg patent value: 8.82 M
2
Medicine,Photomedicine,Drug carrier,
...[+2]
Avg patent value: 8.63 M
3
Avg patent value: 8.45 M
4
Avg patent value: 7.73 M
5
Avg patent value: 5.74 M
6
Avg patent value: 4.94 M
7
Antibody,Medicine,Pharmacy and Therapeutics,
...[+2]
Avg patent value: 3.20 M
8
Avg patent value: 2.99 M
9
Avg patent value: 2.43 M
10
Physical fitness,Health care
Avg patent value: 430,000
11
Avg patent value: 410,000
12
Avg patent value: 280,000
13
Technology transfer,Angel investor,Ecosystem,
...[+2]
Avg patent value: 164,333
14
Biology,Health care,Wellness Programs,
...[+2]
Avg patent value: 85,000
15
Medicine,Health care,Side effect,
...[+2]
Avg patent value: 50,000
16
Avg patent value: 50,000
17
Avg patent value: 18,000
18
Avg patent value: 17,000
19
Avg patent value: 3,500
20
Health care,ADME,Medicinal chemistry,
...[+2]
Avg patent value: 0
Page generation time: Jul 23 2025